Zymergi LogoCart

483 Document: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, Mar 23, 2017

FDANews 483 Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical Mar 23 2017 top
Marcellinus D. Dordunoo FDA Investigator Taichun Qin FDA Investigator Linda F. Murphy FDA Investigator

On Mar 23, 2017, the FDA inspected Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical's Los Angeles site. Explore the inspectional observations.